are instruments used to reduce or halt bleeding during surgery. These can be enabled by the time privileged approaches of smearing pressure, stitching the bleeding or using thermal energy devices. Hemostats generally are used to make the blood clot. Topical hemostatic agents are used in an extensive variety of surgical situations, and the development is a technical advancement in the history of medicine.
Hemostasis, which is a complex process of activating platelets and plasma clotting, can be divided into two distinct processes, primary and secondary hemostasis. Primary hemostasis results in the development of soft platelet plugs, which eventually are steadied and cross-linked through secondary hemostasis. The activation of the clotting cascade is of dominant prominence in both primary and secondary hemostasis. The hemostats market can be divided into by type, treatment and end user segment. Hemostats by product type can be further segmented into thrombin based, collagen based, gelatin based, combination based, oxidized cellulose based and others. These hemostats fin their applications into variety of surgical treatments like cardio therapeutics, spine surgery, pulmonary surgery and many others. The key end users include hospitals, surgery centers, nursing homes and othersThe global market for hemostats
is estimated to be $XX billion in 2015. The global market for hemostats market is forecast to grow at a CAGR of XX% to reach $XX billion by 2021. The main uses of hemostats in everyday surgical practice are neurosurgery like skull and brain injuries, spine and spinal cord surgery, endoscopic surgery and so on. Nowadays, surgery of aneurisms only needs hemostatic agents in the process to shield the brain and halt the indistinct bleedings.
Geographically, the hemostats market has been segmented into four major regions which include Americas, Europe, Asia-Pacific and Rest of the World. Among the four regions Americas was the leading market in 2015 and is estimated to continue with the growing trend. The report delivers an in-depth study on possible prospects of disparate end-users as well as numerous types of hemostats and key markets in each region. The market for hemostats is swiftly growing with technological advancements and cumulative number of surgeries. Also, hospitals and healthcare facilities are gradually growing, maintained by government which in turn is driving the growth of hemostats market. Some of the major companies dealing with the manufacturing of hemostats include:
- Johnson & Johnson Services, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Equimedical (Netherlands)
- B Braun Melsungen AG (Germany)
- Vascular Solutions, Inc. (U.S.)
1. Market Overview
2. Executive Summary
3. Hemostats Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis4. Hemostats Market Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.3. Attractiveness of the Hemostats Industry
4.3.1. Power of Suppliers
4.3.2. Threats From New Entrants
4.3.3. Power of Buyer
4.3.4. Threat From Substitute Product
4.3.5. Degree of Competition5. Hemostats Market-Strategic Analysis
5.1. Hemostats Market - Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle
5.5. Suppliers and Distributors 6. Hemostats Market -By Type
6.1. Thrombin Based Hemostats
6.2. Gelatin Based Hemostats
6.3. Collagen Based Hemostats
6.4. Oxidized Regenerated Cellulose Based Hemostats
6.5. Combination Hemostats
6.6. Others7. Hemostats Market -By Treatment
7.2. Cardio Therapeutics
7.3. Spine Surgery
7.5. Others8. Hemostats Market-By End Users
8.2. Surgery Centres
8.3. Nursing Homes
8.4. Others9. Hemostats Market -By Geography
9.1.5. Rest of Americas
9.2.5. Rest of Europe
9.3. Asia- Pacific
9.3.2. Australia & New Zealand
9.3.5. Rest of APAC
9.4. Rest of the World (RoW)
9.4.1. Middle East
9.4.2. Africa10. Hemostats Market Entropy
10.1. New Product Developments
10.2. Product Launchers, JVs, Mergers and Acquisitions11. Company Profiles
11.1. Collagen Matrix, Inc.
11.2. Ceremed, Inc.
11.3. Bioster Group
11.4. Arc Therapeutics Ltd.
11.5. Angiotech Pharmaceuticals
11.6. Hemcon Medical Technologies
11.7. Harvest Technologies Pvt Ltd.
11.8. Entegrion, Inc
11.9. Plasma Technologies
11.10. Polyheal Ltd.
11.11. Omrix Biopharmaceuticals Ltd.
11.12. Nycomed Pharmaceutical Company Ltd.
11.13. Medtrade Products
11.14. Advance Medical Solution Group PLC
11.15. Zymogenetics Company
11.16. Thrombotargets Corporation
11.17. Starch Medical Inc.
11.18. Scion Cardio-Vascular, Inc.
11.19. Resorbal Wundversorgung GmbH & Co.
11.20. Johnson & Johnson Services, Inc.
11.21. C. R. Bard, Inc.
11.22. Baxter Pvt Ltd.
11.23. Braun Melsungen AG
11.24. Pfizer Inc.
11.25. Tedpella, Inc.
11.26. World Precision Instruments, Inc.
11.27. TZ Medical, Inc.
11.28. Liberty Expert Group, Inc.
11.29. Excel Hobby Blades Corp.
11.30. Jameco Electronics Components & Computer Products
11.31. Vascular Solutions, Inc.*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12.1. List of Abbreviations
12.3. Research Methodology
12.4. Expert Insights